United States - English - NLM (National Library of Medicine)

western family foods inc - loratadine (unii: 7ajo3bo7qn) (loratadine - unii:7ajo3bo7qn) - antihistamine temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: - runny nose - itchy, watery eyes - sneezing - itching of the nose or throat

United States - English - NLM (National Library of Medicine)

western family foods inc - cetirizine hydrochloride (unii: 64o047ktoa) (cetirizine - unii:yo7261me24) - antihistamine temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: - runny nose - itchy, watery eyes - sneezing - itching of the nose or throat

United States - English - NLM (National Library of Medicine)

western family foods, inc. - avobenzone   2.0%, homosalate   10.0%, octisalate       5.0%, octocrylene    5.0% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decrease the risk of skin cancer and early skin aging caused by the sun. if rash occurs

Israel - English - Ministry of Health

ferring pharmaceuticals ltd - menotrophin - powder and solvent for solution for injection - menotrophin 75 iu/dose - human menopausal gonadotrophin - sterility in females with hypo or normogonadotropic ovarian insufficiency : stimulation of follicle growth. sterility in males with hypo or normogonadotropic hypogonadism: in combination with hcg to spermatogenesis.

United States - English - NLM (National Library of Medicine)

professional complementary health formulas - west nile virus 12x, 30x, 60x, 100x - for the temporary relief of fatigue, occasional headache, body aches, minor joint pain, vomiting, diarrhea, or mild skin rash.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

United States - English - NLM (National Library of Medicine)

east coast medicinals - methyl salicylate >1%........................... topical analgesic, methyl salicylate >1%........................... topical analgesic - temporary relief of aches and pains associated with: arthritis, carpal tunnel, rheumatoid arthritis, swelling, sprains & inflammation

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

brewers) 100dbu/ml solution for skin prick test (lofarma - yeast (brewers) allergen extract - solution for skin-prick test

Australia - English - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - yeast dried, quantity: 500 mg - tablet, uncoated - excipient ingredients: magnesium stearate; silicon dioxide; microcrystalline cellulose; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; sodium starch glycollate - nourish the body ; maintain/support general health and wellbeing ; maintain/support (state vitamin/mineral/nutrient) levels in the body

United States - English - NLM (National Library of Medicine)

west-ward pharmaceutical corp - primidone (unii: 13afd7670q) (primidone - unii:13afd7670q) - primidone 250 mg - primidone tablets, usp used alone or concomitantly with other anticonvulsants, are indicated in the control of grand mal, psychomotor, and focal epileptic seizures. it may control grand mal seizures refractory to other anticonvulsant therapy. primidone is contraindicated in: - patients with porphyria and - patients who are hypersensitive to phenobarbital (see clinical pharmacology ).

Australia - English - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - raloxifene hydrochloride, quantity: 60 mg - tablet, film coated - excipient ingredients: crospovidone; polysorbate 80; magnesium stearate; lactose monohydrate; lactose; povidone; carnauba wax; colour; propylene glycol; indigo carmine; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; industrial methylated spirit; ethanol - evista is indicated for the prevention and treatment of osteoporosis in post-menopausal women. evista is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis. evista is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer. high risk of breast cancer is defined as at least one breast biopsy showing lobular carcinoma in situ (lcis) or atypical hyperplasia, one or more first-degree relatives with breast cancer, or a 5-year predicted risk of breast cancer >1.66% (based on the modified gail model). among the factors included in the modified gail model are the following: current age, number of first-degree relatives with breast cancer, number of breast biopsies, age at menarche, nulliparity or age of first live birth. currently, no single clinical finding or test result can quantify risk of breast cancer with certainty.